NEW DELHI: The government will launch the Covid-19 vaccine next week, and Health Secretary Rajesh Bhushan said this would happen within 10 days after the emergency use authorization being granted. The Indian regulator granted the EUA on January 3. This is the first time the government has officially spoken of …
Read More »
Bharat Biotech vaccine candidate approved for use in clinical trial mode. The first COVID-19 vaccine developed in India, Covaxin, has been recommended for “restricted use in emergency situations, subject to multiple regulatory conditions” by the Subject Matter Expert Committee (SEC) of the Central Medicines Control Organization ( CDSCO), here on …
Read More »
Covaxin has been indigenously developed in collaboration with ICMR. An expert panel from India’s central drug authority recommended on January 2 to grant permission for the emergency restricted use of the locally developed COVID-19 vaccine Covaxin with certain conditions, a day after giving similar instructions for the COVID vaccine. -19 …
Read More »
The third ongoing vaccine, Bharat Biotech’s Covaxin, which is being developed in collaboration with the Indian Council for Medical Research (ICMR), is simultaneously undergoing Phase 3 human trials at 22 sites in India with around 26,000 volunteers. . According to a senior company official, it will be at least 60 …
Read More »
NEW DELHI: Pfizer India has become the first pharmaceutical company to approach the Comptroller General of Medicines of India (DCGI) seeking an emergency use authorization for its Covid-19 vaccine in the country. It should be noted that Pfizer India’s parent company Pfizer has already obtained emergency use authorization in the …
Read More »
At a time when we are all desperately waiting for a vaccine to reduce the spread of the new coronavirus, the American pharmaceutical company confirmed that Pfizer Inc and its German partner BioNTech have formally applied to the US Food and Drug Administration (FDA ) an emergency use authorization. for …
Read More »